Relay Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Relay Therapeutics, Inc. (RLAY) reported Basic Shares Outstanding (Weighted Average) of 202.85 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- Relay Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 202.85M shares, a 18.44% increase year-over-year.
- Relay Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 179.85M shares, a 6.27% increase year-over-year.
- Relay Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 173.42M shares, a 3.53% increase year-over-year.
- Relay Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 172.39M shares, a 22.93% increase year-over-year.
- Relay Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 171.59M shares, a 20.10% increase from fiscal 2024.
- Relay Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 142.87M shares, a 16.55% increase from fiscal 2023.
- Relay Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 122.58M shares, a 9.22% increase from fiscal 2022.
- Relay Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 112.23M shares, a 17.97% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 202.85M shares 10-Q · filed 2026-08-06 | 191.41M shares 10-Q · filed 2026-08-06 | 185.37M shares derived: average of 3 quarters · filed 2026-08-06 | 182.13M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 179.85M shares 10-Q · filed 2026-05-05 | 176.64M shares derived: average of 2 quarters · filed 2026-05-05 | 175.22M shares derived: average of 3 quarters · filed 2026-05-05 | 174.23M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 173.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 172.91M shares derived: average of 2 quarters · filed 2026-02-26 | 172.36M shares derived: average of 3 quarters · filed 2026-08-06 | 171.59M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 172.39M shares 10-Q · filed 2025-11-06 | 171.83M shares derived: average of 2 quarters · filed 2026-08-06 | 170.97M shares 10-Q · filed 2025-11-06 | 170.10M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 171.26M shares 10-Q · filed 2026-08-06 | 170.25M shares 10-Q · filed 2026-08-06 | 169.34M shares derived: average of 3 quarters · filed 2026-08-06 | 162.06M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 169.23M shares 10-Q · filed 2026-05-05 | 168.37M shares derived: average of 2 quarters · filed 2026-05-05 | 158.99M shares derived: average of 3 quarters · filed 2026-05-05 | 152.45M shares derived: average of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | 167.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 153.87M shares derived: average of 2 quarters · filed 2026-02-26 | 146.86M shares derived: average of 3 quarters · filed 2026-02-26 | 142.87M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 140.23M shares 10-Q · filed 2025-11-06 | 136.53M shares derived: average of 2 quarters · filed 2025-11-06 | 134.65M shares 10-Q · filed 2025-11-06 | 132.17M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 132.82M shares 10-Q · filed 2025-08-07 | 131.83M shares 10-Q · filed 2025-08-07 | 129.48M shares derived: average of 3 quarters · filed 2026-02-26 | 127.67M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 130.84M shares 10-Q · filed 2025-05-05 | 127.81M shares derived: average of 2 quarters · filed 2026-02-26 | 125.95M shares derived: average of 3 quarters · filed 2026-02-26 | 124.88M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 124.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 123.50M shares derived: average of 2 quarters · filed 2026-02-26 | 122.90M shares derived: average of 3 quarters · filed 2026-02-26 | 122.58M shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 122.23M shares 10-Q · filed 2024-11-06 | 121.96M shares derived: average of 2 quarters · filed 2024-11-06 | 121.84M shares 10-Q · filed 2024-11-06 | 121.57M shares derived: average of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | 121.68M shares 10-Q · filed 2024-08-06 | 121.50M shares 10-Q · filed 2024-08-06 | 121.35M shares derived: average of 3 quarters · filed 2025-02-26 | 118.74M shares derived: average of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | 121.32M shares 10-Q · filed 2024-05-02 | 121.19M shares derived: average of 2 quarters · filed 2025-02-26 | 117.76M shares derived: average of 3 quarters · filed 2025-02-26 | 115.48M shares derived: average of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | 121.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | 115.98M shares derived: average of 2 quarters · filed 2025-02-26 | 113.54M shares derived: average of 3 quarters · filed 2025-02-26 | 112.23M shares 10-K · filed 2025-02-26 |
| 2022-09-30 | 110.91M shares 10-Q · filed 2023-11-02 | 109.78M shares derived: average of 2 quarters · filed 2023-11-02 | 109.29M shares 10-Q · filed 2023-11-02 | 107.65M shares derived: average of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | 108.64M shares 10-Q · filed 2023-08-08 | 108.47M shares 10-Q · filed 2023-08-08 | 106.56M shares derived: average of 3 quarters · filed 2024-02-22 | 103.09M shares derived: average of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | 108.29M shares 10-Q · filed 2023-05-04 | 105.52M shares derived: average of 2 quarters · filed 2024-02-22 | 101.24M shares derived: average of 3 quarters · filed 2024-02-22 | |
| 2021-12-31 | 102.75M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | 97.72M shares derived: average of 2 quarters · filed 2024-02-22 | 95.14M shares 10-K · filed 2024-02-22 | |
| 2021-09-30 | 92.69M shares 10-Q · filed 2022-11-03 | 92.60M shares 10-Q · filed 2022-11-03 | ||
| 2020-12-31 | 42.62M shares 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |